Use  ||| S:0 E:4 ||| NN
of  ||| S:4 E:7 ||| IN
a  ||| S:7 E:9 ||| DT
novel  ||| S:9 E:15 ||| NN
diagonal  ||| S:15 E:24 ||| NNS
pump  ||| S:24 E:29 ||| VBP
in  ||| S:29 E:32 ||| IN
an  ||| S:32 E:35 ||| DT
in  ||| S:35 E:38 ||| FW
vitro  ||| S:38 E:44 ||| FW
neonatal  ||| S:44 E:53 ||| FW
pulsatile  ||| S:53 E:63 ||| FW
extracorporeal  ||| S:63 E:78 ||| FW
life  ||| S:78 E:83 ||| NN
support  ||| S:83 E:91 ||| NN
circuit  ||| S:91 E:99 ||| NN
One  ||| S:99 E:103 ||| CD
approach  ||| S:103 E:112 ||| NN
with  ||| S:112 E:117 ||| IN
the  ||| S:117 E:121 ||| DT
potential  ||| S:121 E:131 ||| JJ
to  ||| S:131 E:134 ||| TO
improve  ||| S:134 E:142 ||| VB
morbidity  ||| S:142 E:152 ||| NN
and  ||| S:152 E:156 ||| CC
mortality  ||| S:156 E:166 ||| NN
rates  ||| S:166 E:172 ||| NNS
following  ||| S:172 E:182 ||| VBG
extracorporeal  ||| S:182 E:197 ||| JJ
life  ||| S:197 E:202 ||| NN
support  ||| S:202 E:210 ||| NN
( ||| S:210 E:211 ||| -LRB-
ECLS ||| S:211 E:215 ||| NNP
)  ||| S:215 E:217 ||| -RRB-
is  ||| S:217 E:220 ||| VBZ
the  ||| S:220 E:224 ||| DT
use  ||| S:224 E:228 ||| NN
of  ||| S:228 E:231 ||| IN
pulsatile  ||| S:231 E:241 ||| JJ
perfusion ||| S:241 E:250 ||| NN
.  ||| S:250 E:252 ||| .
Currently ||| S:252 E:261 ||| RB
,  ||| S:261 E:263 ||| ,
no  ||| S:263 E:266 ||| DT
ECLS  ||| S:266 E:271 ||| NNP
pumps  ||| S:271 E:277 ||| NNS
used  ||| S:277 E:282 ||| VBN
in  ||| S:282 E:285 ||| IN
the  ||| S:285 E:289 ||| DT
United  ||| S:289 E:296 ||| NNP
States  ||| S:296 E:303 ||| NNPS
can  ||| S:303 E:307 ||| MD
produce  ||| S:307 E:315 ||| VB
pulsatile  ||| S:315 E:325 ||| JJ
flow ||| S:325 E:329 ||| NN
.  ||| S:329 E:331 ||| .
The  ||| S:331 E:335 ||| DT
objective  ||| S:335 E:345 ||| NN
of  ||| S:345 E:348 ||| IN
this  ||| S:348 E:353 ||| DT
experiment  ||| S:353 E:364 ||| NN
is  ||| S:364 E:367 ||| VBZ
to  ||| S:367 E:370 ||| TO
evaluate  ||| S:370 E:379 ||| VB
a  ||| S:379 E:381 ||| DT
novel  ||| S:381 E:387 ||| NN
diagonal  ||| S:387 E:396 ||| NNS
pump  ||| S:396 E:401 ||| VBP
used  ||| S:401 E:406 ||| VBN
in  ||| S:406 E:409 ||| IN
Europe  ||| S:409 E:416 ||| NNP
to  ||| S:416 E:419 ||| TO
determine  ||| S:419 E:429 ||| VB
whether  ||| S:429 E:437 ||| IN
it  ||| S:437 E:440 ||| PRP
provides  ||| S:440 E:449 ||| VBZ
physiological  ||| S:449 E:463 ||| JJ
pulsatility  ||| S:463 E:475 ||| NN
in  ||| S:475 E:478 ||| IN
a  ||| S:478 E:480 ||| DT
neonatal  ||| S:480 E:489 ||| JJ
model ||| S:489 E:494 ||| NN
.  ||| S:494 E:496 ||| .
The  ||| S:496 E:500 ||| DT
ECLS  ||| S:500 E:505 ||| NNP
circuit  ||| S:505 E:513 ||| NN
consisted  ||| S:513 E:523 ||| VBD
of  ||| S:523 E:526 ||| IN
a  ||| S:526 E:528 ||| DT
Medos  ||| S:528 E:534 ||| NNP
Deltastream  ||| S:534 E:546 ||| NNP
DP3  ||| S:546 E:550 ||| NNP
diagonal  ||| S:550 E:559 ||| JJ
pump ||| S:559 E:563 ||| NN
,  ||| S:563 E:565 ||| ,
a  ||| S:565 E:567 ||| DT
Hilite  ||| S:567 E:574 ||| NNP
800LT  ||| S:574 E:580 ||| FW
polymethylpentene  ||| S:580 E:598 ||| FW
diffusion  ||| S:598 E:608 ||| FW
membrane  ||| S:608 E:617 ||| FW
oxygenator ||| S:617 E:627 ||| FW
,  ||| S:627 E:629 ||| ,
and  ||| S:629 E:633 ||| CC
arterial ||| S:633 E:641 ||| FW
/ ||| S:641 E:642 ||| FW
venous  ||| S:642 E:649 ||| FW
tubing ||| S:649 E:655 ||| FW
.  ||| S:655 E:657 ||| .
A  ||| S:657 E:659 ||| DT
300-mL  ||| S:659 E:666 ||| CD
pseudopatient  ||| S:666 E:680 ||| NNS
was  ||| S:680 E:684 ||| VBD
connected  ||| S:684 E:694 ||| VBN
to  ||| S:694 E:697 ||| TO
the  ||| S:697 E:701 ||| DT
circuit  ||| S:701 E:709 ||| NN
using  ||| S:709 E:715 ||| VBG
an  ||| S:715 E:718 ||| DT
8Fr  ||| S:718 E:722 ||| CD
arterial  ||| S:722 E:731 ||| CD
cannula  ||| S:731 E:739 ||| NNS
and  ||| S:739 E:743 ||| CC
a  ||| S:743 E:745 ||| DT
10Fr  ||| S:745 E:750 ||| FW
venous  ||| S:750 E:757 ||| FW
cannula ||| S:757 E:764 ||| FW
.  ||| S:764 E:766 ||| .
A  ||| S:766 E:768 ||| DT
clamp  ||| S:768 E:774 ||| NN
maintained  ||| S:774 E:785 ||| VBD
constant  ||| S:785 E:794 ||| JJ
pressure  ||| S:794 E:803 ||| NN
entering  ||| S:803 E:812 ||| VBG
the  ||| S:812 E:816 ||| DT
pseudopatient ||| S:816 E:829 ||| NN
.  ||| S:829 E:831 ||| .
Trials  ||| S:831 E:838 ||| NNS
( ||| S:838 E:839 ||| -LRB-
64  ||| S:839 E:842 ||| CD
total ||| S:842 E:847 ||| NN
)  ||| S:847 E:849 ||| -RRB-
were  ||| S:849 E:854 ||| VBD
conducted  ||| S:854 E:864 ||| VBN
in  ||| S:864 E:867 ||| IN
nonpulsatile  ||| S:867 E:880 ||| NN
and  ||| S:880 E:884 ||| CC
pulsatile  ||| S:884 E:894 ||| JJ
modes  ||| S:894 E:900 ||| NNS
at  ||| S:900 E:903 ||| IN
flow  ||| S:903 E:908 ||| NN
rates  ||| S:908 E:914 ||| NNS
of  ||| S:914 E:917 ||| IN
200  ||| S:917 E:921 ||| NNP
mL ||| S:921 E:923 ||| NNP
/ ||| S:923 E:924 ||| NNP
min  ||| S:924 E:928 ||| VBD
to  ||| S:928 E:931 ||| TO
800  ||| S:931 E:935 ||| CD
mL ||| S:935 E:937 ||| JJ
/ ||| S:937 E:938 ||| CD
min ||| S:938 E:941 ||| NNS
.  ||| S:941 E:943 ||| .
Flow  ||| S:943 E:948 ||| NN
and  ||| S:948 E:952 ||| CC
pressure  ||| S:952 E:961 ||| NN
data  ||| S:961 E:966 ||| NNS
were  ||| S:966 E:971 ||| VBD
collected  ||| S:971 E:981 ||| VBN
using  ||| S:981 E:987 ||| VBG
a  ||| S:987 E:989 ||| DT
custom-based  ||| S:989 E:1002 ||| JJ
data  ||| S:1002 E:1007 ||| NN
acquisition  ||| S:1007 E:1019 ||| NN
system ||| S:1019 E:1025 ||| NN
.  ||| S:1025 E:1027 ||| .
The  ||| S:1027 E:1031 ||| DT
Deltastream  ||| S:1031 E:1043 ||| NNP
DP3  ||| S:1043 E:1047 ||| NNP
pump  ||| S:1047 E:1052 ||| NN
was  ||| S:1052 E:1056 ||| VBD
capable  ||| S:1056 E:1064 ||| JJ
of  ||| S:1064 E:1067 ||| IN
producing  ||| S:1067 E:1077 ||| VBG
an  ||| S:1077 E:1080 ||| DT
adequate  ||| S:1080 E:1089 ||| JJ
quality  ||| S:1089 E:1097 ||| NN
of  ||| S:1097 E:1100 ||| IN
pulsatility ||| S:1100 E:1111 ||| NN
.  ||| S:1111 E:1113 ||| .
Pulsatile  ||| S:1113 E:1123 ||| JJ
flow  ||| S:1123 E:1128 ||| NN
produced  ||| S:1128 E:1137 ||| VBD
increased  ||| S:1137 E:1147 ||| VBN
mean  ||| S:1147 E:1152 ||| JJ
arterial  ||| S:1152 E:1161 ||| JJ
pressure ||| S:1161 E:1169 ||| NN
,  ||| S:1169 E:1171 ||| ,
energy  ||| S:1171 E:1178 ||| NN
equivalent  ||| S:1178 E:1189 ||| NN
pressure  ||| S:1189 E:1198 ||| NN
( ||| S:1198 E:1199 ||| -LRB-
EEP ||| S:1199 E:1202 ||| NNP
) ||| S:1202 E:1203 ||| -RRB-
,  ||| S:1203 E:1205 ||| ,
and  ||| S:1205 E:1209 ||| CC
surplus  ||| S:1209 E:1217 ||| NN
hemodynamic  ||| S:1217 E:1229 ||| NN
energy  ||| S:1229 E:1236 ||| NN
( ||| S:1236 E:1237 ||| -LRB-
SHE ||| S:1237 E:1240 ||| NNP
)  ||| S:1240 E:1242 ||| -RRB-
at  ||| S:1242 E:1245 ||| IN
all  ||| S:1245 E:1249 ||| DT
flow  ||| S:1249 E:1254 ||| NN
rates  ||| S:1254 E:1260 ||| NNS
compared  ||| S:1260 E:1269 ||| VBN
to  ||| S:1269 E:1272 ||| TO
nonpulsatile  ||| S:1272 E:1285 ||| VB
flow ||| S:1285 E:1289 ||| NN
.  ||| S:1289 E:1291 ||| .
Pressure  ||| S:1291 E:1300 ||| NN
drop  ||| S:1300 E:1305 ||| NN
across  ||| S:1305 E:1312 ||| IN
the  ||| S:1312 E:1316 ||| DT
cannula  ||| S:1316 E:1324 ||| NN
accounted  ||| S:1324 E:1334 ||| VBD
for  ||| S:1334 E:1338 ||| IN
the  ||| S:1338 E:1342 ||| DT
majority  ||| S:1342 E:1351 ||| NN
of  ||| S:1351 E:1354 ||| IN
pressure  ||| S:1354 E:1363 ||| NN
loss  ||| S:1363 E:1368 ||| NN
in  ||| S:1368 E:1371 ||| IN
the  ||| S:1371 E:1375 ||| DT
circuit ||| S:1375 E:1382 ||| NN
.  ||| S:1382 E:1384 ||| .
The  ||| S:1384 E:1388 ||| DT
greatest  ||| S:1388 E:1397 ||| JJS
loss  ||| S:1397 E:1402 ||| NN
of  ||| S:1402 E:1405 ||| IN
SHE  ||| S:1405 E:1409 ||| NNP
and  ||| S:1409 E:1413 ||| CC
total  ||| S:1413 E:1419 ||| JJ
hemodynamic  ||| S:1419 E:1431 ||| JJ
energy  ||| S:1431 E:1438 ||| NN
occurred  ||| S:1438 E:1447 ||| VBD
across  ||| S:1447 E:1454 ||| IN
the  ||| S:1454 E:1458 ||| DT
arterial  ||| S:1458 E:1467 ||| JJ
cannula  ||| S:1467 E:1475 ||| JJ
due  ||| S:1475 E:1479 ||| JJ
to  ||| S:1479 E:1482 ||| TO
its  ||| S:1482 E:1486 ||| PRP$
small  ||| S:1486 E:1492 ||| JJ
diameter ||| S:1492 E:1500 ||| NN
.  ||| S:1500 E:1502 ||| .
The  ||| S:1502 E:1506 ||| DT
Deltastream  ||| S:1506 E:1518 ||| NNP
DP3  ||| S:1518 E:1522 ||| NNP
pump  ||| S:1522 E:1527 ||| VBP
produced  ||| S:1527 E:1536 ||| VBN
physiological  ||| S:1536 E:1550 ||| JJ
pulsatile  ||| S:1550 E:1560 ||| JJ
flow  ||| S:1560 E:1565 ||| NN
without  ||| S:1565 E:1573 ||| IN
backflow  ||| S:1573 E:1582 ||| NN
while  ||| S:1582 E:1588 ||| IN
providing  ||| S:1588 E:1598 ||| VBG
EEP  ||| S:1598 E:1602 ||| NNP
and  ||| S:1602 E:1606 ||| CC
SHE  ||| S:1606 E:1610 ||| NNP
to  ||| S:1610 E:1613 ||| TO
our  ||| S:1613 E:1617 ||| PRP$
neonatal  ||| S:1617 E:1626 ||| JJ
pseudopatient ||| S:1626 E:1639 ||| NN
.  ||| S:1639 E:1641 ||| .
Further  ||| S:1641 E:1649 ||| JJ
experiments  ||| S:1649 E:1661 ||| NNS
are  ||| S:1661 E:1665 ||| VBP
necessary  ||| S:1665 E:1675 ||| JJ
to  ||| S:1675 E:1678 ||| TO
determine  ||| S:1678 E:1688 ||| VB
the  ||| S:1688 E:1692 ||| DT
impact  ||| S:1692 E:1699 ||| NN
of  ||| S:1699 E:1702 ||| IN
this  ||| S:1702 E:1707 ||| DT
pulsatile  ||| S:1707 E:1717 ||| JJ
pump  ||| S:1717 E:1722 ||| NN
in  ||| S:1722 E:1725 ||| IN
an  ||| S:1725 E:1728 ||| DT
in  ||| S:1728 E:1731 ||| IN
vivo  ||| S:1731 E:1736 ||| JJ
model  ||| S:1736 E:1742 ||| NN
prior  ||| S:1742 E:1748 ||| RB
to  ||| S:1748 E:1751 ||| TO
clinical  ||| S:1751 E:1760 ||| JJ
use ||| S:1760 E:1763 ||| NN
.  ||| S:1763 E:1765 ||| .
